Patents by Inventor Paul Meltzer

Paul Meltzer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140221234
    Abstract: A method of diagnosing, predicting, or prognosticating about a disease that includes obtaining experimental data, wherein the experimental data is high dimensional data, filtering the data, reducing the dimensionality of the data through use of one or more methods, training a supervised pattern recognition method, ranking individual data points from the data, wherein the ranking is dependent on the outcome of the supervised pattern recognition method, choosing multiple data points from the data, wherein the choice is based on the relative ranking of the individual data points, and using the multiple data points to determine if an unknown set of experimental data indicates a diseased condition, a predilection for a diseased condition, or a prognosis about a diseased condition.
    Type: Application
    Filed: December 30, 2013
    Publication date: August 7, 2014
    Applicant: Government of the United States Represented by the Secretary, Department of Health and Human Service
    Inventors: Javed Khan, Markus Ringner, Carsten Peterson, Paul Meltzer
  • Patent number: 8620592
    Abstract: A method of diagnosing, predicting, or prognosticating about a disease that includes obtaining experimental data, wherein the experimental data is high dimensional data, filtering the data, reducing the dimensionality of the data through use of one or more methods, training a supervised pattern recognition method, ranking individual data points from the data, wherein the ranking is dependent on the outcome of the supervised pattern recognition method, choosing multiple data points from the data, wherein the choice is based on the relative ranking of the individual data points, and using the multiple data points to determine if an unknown set of experimental data indicates a diseased condition, a predilection for a diseased condition, or a prognosis about a diseased condition.
    Type: Grant
    Filed: October 31, 2011
    Date of Patent: December 31, 2013
    Assignee: The United States of America Represented by the Secretary, Department of Health and Human Services
    Inventors: Javed Khan, Markus Ringner, Carsten Peterson, Paul Meltzer
  • Patent number: 8263759
    Abstract: A method of diagnosing a disease that includes obtaining experimental data on gene selections. The gene selection functions to characterize a cancer when the expression of that gene selection is compared to the identical selection from a noncancerous cell or a different type of cancer cell. The invention also includes a method of targeting at least one product of a gene that includes administration of a therapeutic agent. The invention also includes the use of a gene selection for diagnosing a cancer.
    Type: Grant
    Filed: October 30, 2007
    Date of Patent: September 11, 2012
    Assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services
    Inventors: Javed Khan, Markus Ringner, Carsten Peterson, Paul Meltzer
  • Publication number: 20120046878
    Abstract: A method of diagnosing, predicting, or prognosticating about a disease that includes obtaining experimental data, wherein the experimental data is high dimensional data, filtering the data, reducing the dimensionality of the data through use of one or more methods, training a supervised pattern recognition method, ranking individual data points from the data, wherein the ranking is dependent on the outcome of the supervised pattern recognition method, choosing multiple data points from the data, wherein the choice is based on the relative ranking of the individual data points, and using the multiple data points to determine if an unknown set of experimental data indicates a diseased condition, a predilection for a diseased condition, or a prognosis about a diseased condition.
    Type: Application
    Filed: October 31, 2011
    Publication date: February 23, 2012
    Applicants: SERVICES
    Inventors: JAVED KHAN, MARKUS RINGNÉR, CARSTEN PETERSON, PAUL MELTZER
  • Patent number: 8065092
    Abstract: A method of diagnosing, predicting, or prognosticating about a disease that includes obtaining experimental data, wherein the experimental data is high dimensional data, filtering the data, reducing the dimensionality of the data through use of one or more methods, training a supervised pattern recognition method, ranking individual data points from the data, wherein the ranking is dependent on the outcome of the supervised pattern recognition method, choosing multiple data points from the data, wherein the choice is based on the relative ranking of the individual data points, and using the multiple data points to determine if an unknown set of experimental data indicates a diseased condition, a predilection for a diseased condition, or a prognosis about a diseased condition.
    Type: Grant
    Filed: August 18, 2010
    Date of Patent: November 22, 2011
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Javed Khan, Markus Ringnér, Carsten Peterson, Paul Meltzer
  • Publication number: 20100312486
    Abstract: A method of diagnosing, predicting, or prognosticating about a disease that includes obtaining experimental data, wherein the experimental data is high dimensional data, filtering the data, reducing the dimensionality of the data through use of one or more methods, training a supervised pattern recognition method, ranking individual data points from the data, wherein the ranking is dependent on the outcome of the supervised pattern recognition method, choosing multiple data points from the data, wherein the choice is based on the relative ranking of the individual data points, and using the multiple data points to determine if an unknown set of experimental data indicates a diseased condition, a predilection for a diseased condition, or a prognosis about a diseased condition.
    Type: Application
    Filed: August 18, 2010
    Publication date: December 9, 2010
    Applicant: Government of the USA represented by the Secretary Dept. of Health and Human Services
    Inventors: Javed Khan, Markus Ringnér, Carsten Peterson, Paul Meltzer
  • Patent number: 7783431
    Abstract: A method of diagnosing, predicting, or prognosticating about a disease that includes obtaining experimental data, wherein the experimental data is high dimensional data, filtering the data, reducing the dimensionality of the data through use of one or more methods, training a supervised pattern recognition method, ranking individual data points from the data, wherein the ranking is dependent on the outcome of the supervised pattern recognition method, choosing multiple data points from the data, wherein the choice is based on the relative ranking of the individual data points, and using the multiple data points to determine if an unknown set of experimental data indicates a diseased condition, a predilection for a diseased condition, or a prognosis about a diseased condition.
    Type: Grant
    Filed: October 30, 2007
    Date of Patent: August 24, 2010
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Javed Khan, Markus Ringner, Carsten Peterson, Paul Meltzer
  • Patent number: 7774143
    Abstract: A method of diagnosing, predicting, or prognosticating about a disease that includes obtaining experimental data, wherein the experimental data is high dimensional data, filtering the data, reducing the dimensionality of the data through use of one or more methods, training a supervised pattern recognition method, ranking individual data points from the data, wherein the ranking is dependent on the outcome of the supervised pattern recognition method, choosing multiple data points from the data, wherein the choice is based on the relative ranking of the individual data points, and using the multiple data points to determine if an unknown set of experimental data indicates a diseased condition, a predilection for a diseased condition, or a prognosis about a diseased condition.
    Type: Grant
    Filed: April 25, 2002
    Date of Patent: August 10, 2010
    Assignee: The United States of America as represented by the Secretary, Department of Health and Human Services
    Inventors: Javed Khan, Markus Ringnér, Carsten Peterson, Paul Meltzer
  • Patent number: 7655397
    Abstract: A method of diagnosing a disease that includes obtaining experimental data on gene selections. The gene selection functions to characterize a cancer when the expression of that gene selection is compared to the identical selection from a noncancerous cell or a different type of cancer cell. The invention also includes a method of targeting at least one product of a gene that includes administration of a therapeutic agent. The invention also includes the use of a gene selection for diagnosing a cancer.
    Type: Grant
    Filed: May 31, 2002
    Date of Patent: February 2, 2010
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Javed Khan, Markus Ringnér, Carsten Peterson, Paul Meltzer
  • Publication number: 20090035766
    Abstract: A method of diagnosing, predicting, or prognosticating about a disease that includes obtaining experimental data, wherein the experimental data is high dimensional data, filtering the data, reducing the dimensionality of the data through use of one or more methods, training a supervised pattern recognition method, ranking individual data points from the data, wherein the ranking is dependent on the outcome of the supervised pattern recognition method, choosing multiple data points from the data, wherein the choice is based on the relative ranking of the individual data points, and using the multiple data points to determine if an unknown set of experimental data indicates a diseased condition, a predilection for a diseased condition, or a prognosis about a diseased condition.
    Type: Application
    Filed: October 30, 2007
    Publication date: February 5, 2009
    Applicants: SERVICES
    Inventors: Javed Khan, Markus Ringner, Carsten Peterson, Paul Meltzer
  • Publication number: 20090023645
    Abstract: The invention features a substantially pure DNA which includes a sequence encoding a novel steroid receptor co-activator which is overexpressed in breast cancer cells, diagnostic assays for steroid hormone-responsive cancers, and screening assays to identify compounds which inhibit an interaction of the co-activator with the steroid hormone.
    Type: Application
    Filed: April 24, 2007
    Publication date: January 22, 2009
    Inventors: Paul Meltzer, Jeffrey Trent
  • Publication number: 20080181896
    Abstract: A method of diagnosing a disease that includes obtaining experimental data on gene selections. The gene selection functions to characterize a cancer when the expression of that gene selection is compared to the identical selection from a noncancerous cell or a different type of cancer cell. The invention also includes a method of targeting at least one product of a gene that includes administration of a therapeutic agent. The invention also includes the use of a gene selection for diagnosing a cancer.
    Type: Application
    Filed: October 30, 2007
    Publication date: July 31, 2008
    Applicants: DEPARTMENT OF HEALTH AND HUMAN SERVICES
    Inventors: Javed Khan, Markus Ringner, Carsten Peterson, Paul Meltzer
  • Patent number: 7247426
    Abstract: The overexpression of certain marker genes including Wnt5a has been found useful in the identification of more aggressive forms of malignant melanoma. Therefore, the overexpression of these genes in tumor samples of malignant melanoma may be useful in the diagnosis, profiling, and treatment of patients suffering from this disease. Inhibitors of Wnt5a activity may be useful in the treatment of aggressive forms of malignant melanoma. Inhibition of Wnt5a activity may be effected by any method including anti-sense therapy, gene therapy, and pharmaceutical intervention.
    Type: Grant
    Filed: August 2, 2001
    Date of Patent: July 24, 2007
    Assignee: Agilent Technologies, Inc.
    Inventors: Zohar Yakhini, Michael Bittner, Jeff Trent, Amir Ben-Dor, Paul Meltzer, Yidong Chen, Ashani Weeraratna, Yuan Jiang, Nick Sampas, Edward Dougherty
  • Patent number: 7232890
    Abstract: The invention features a substantially pure DNA which includes a sequence encoding a novel steroid receptor co-activator which is overexpressed in breast cancer cells, diagnostic assays for steroid hormone-responsive cancers, and screening assays to identify compounds which inhibit an interaction of the co-activator with the steroid hormone.
    Type: Grant
    Filed: March 4, 2003
    Date of Patent: June 19, 2007
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Paul Meltzer, Jeffrey M. Trent
  • Publication number: 20040009154
    Abstract: A method of diagnosing a disease that includes obtaining experimental data on gene selections. The gene selection functions to characterize a cancer when the expression of that gene selection is compared to the identical selection from a noncancerous cell or a different type of cancer cell. The invention also includes a method of targeting at least one product of a gene that includes administration of a therapeutic agent. The invention also includes the use of a gene selection for diagnosing a cancer.
    Type: Application
    Filed: May 31, 2002
    Publication date: January 15, 2004
    Inventors: Javed Khan, Markus Ringner, Carsten Peterson, Paul Meltzer
  • Publication number: 20030207278
    Abstract: A method of diagnosing, predicting, or prognosticating about a disease that includes obtaining experimental data, wherein the experimental data is high dimensional data, filtering the data, reducing the dimensionality of the data through use of one or more methods, training a supervised pattern recognition method, ranking individual data points from the data, wherein the ranking is dependent on the outcome of the supervised pattern recognition method, choosing multiple data points from the data, wherein the choice is based on the relative ranking of the individual data points, and using the multiple data points to determine if an unknown set of experimental data indicates a diseased condition, a predilection for a diseased condition, or a prognosis about a diseased condition.
    Type: Application
    Filed: April 25, 2002
    Publication date: November 6, 2003
    Inventors: Javed Khan, Markus Ringner, Carsten Peterson, Paul Meltzer
  • Publication number: 20030152923
    Abstract: The overexpression of certain marker genes including Wnt5a has been found useful in the identification of more aggressive forms of malignant melanoma. Therefore, the overexpression of these genes in tumor samples of malignant melanoma may be useful in the diagnosis, profiling, and treatment of patients suffering from this disease. Inhibitors of Wnt5a activity may be useful in the treatment of aggressive forms of malignant melanoma. Inhibition of Wnt5a activity may be effected by any method including anti-sense therapy, gene therapy, and pharmaceutical intervention.
    Type: Application
    Filed: August 2, 2001
    Publication date: August 14, 2003
    Inventors: Zohar Yakhini, Michael Bittner, Jeff Trent, Amir Ben-Dor, Paul Meltzer, Yidong Chen, Ashani Weeraratna, Yuan Jiang, Nick Sampas, Edward Dougherty
  • Publication number: 20030153047
    Abstract: The invention features a substantially pure DNA which includes a sequence encoding a novel steroid receptor co-activator which is overexpressed in breast cancer cells, diagnostic assays for steroid hormone-responsive cancers, and screening assays to identify compounds which inhibit an interaction of the co-activator with the steroid hormone.
    Type: Application
    Filed: March 4, 2003
    Publication date: August 14, 2003
    Applicant: The Govt. of the U.S.A. as represented by the Secretary of the Dept. of Health & Human Services
    Inventors: Paul Meltzer, Jeffrey Trent
  • Patent number: 6562589
    Abstract: The invention features a substantially pure DNA which includes a sequence encoding a novel steroid receptor co-activator which is overexpressed in breast cancer cells, diagnostic assays for steroid hormone-responsive cancers, and screening assays to identify compounds which inhibit an interaction of the co-activator with the steroid hormone.
    Type: Grant
    Filed: August 21, 1998
    Date of Patent: May 13, 2003
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Paul Meltzer, Jeffrey Trent
  • Publication number: 20020178185
    Abstract: An interactive software system provides a framework, methodology, and tools for organizing information during speculative phases of research using a narrative structure. The system provides interactive tools and techniques for organizing, sharing, and using diverse information at multiple levels of abstraction through coordinated multiple-view visualization in the process of hypothesis formation. Annotation and collaboration are supported.
    Type: Application
    Filed: May 22, 2002
    Publication date: November 28, 2002
    Inventors: Allan Kuchinsky, David Moh, Katherine D. Graham, Michael L. Creech, Michael Bittner, Paul Meltzer, Yidong Chen